Literature DB >> 25914793

A heterogeneous algorithm for PDT dose optimization for prostate.

Martin D Altschuler1, Timothy C Zhu1, Yida Hu1, Jarod C Finlay1, Andreea Dimofte1, Ken Wang1, Jun Li1, Keith Cengel1, S B Malkowicz2, Stephen M Hahn1.   

Abstract

The object of this study is to develop optimization procedures that account for both the optical heterogeneity as well as photosensitizer (PS) drug distribution of the patient prostate and thereby enable delivery of uniform photodynamic dose to that gland. We use the heterogeneous optical properties measured for a patient prostate to calculate a light fluence kernel (table). PS distribution is then multiplied with the light fluence kernel to form the PDT dose kernel. The Cimmino feasibility algorithm, which is fast, linear, and always converges reliably, is applied as a search tool to choose the weights of the light sources to optimize PDT dose. Maximum and minimum PDT dose limits chosen for sample points in the prostate constrain the solution for the source strengths of the cylindrical diffuser fibers (CDF). We tested the Cimmino optimization procedures using the light fluence kernel generated for heterogeneous optical properties, and compared the optimized treatment plans with those obtained using homogeneous optical properties. To study how different photosensitizer distributions in the prostate affect optimization, comparisons of light fluence rate and PDT dose distributions were made with three distributions of photosensitizer: uniform, linear spatial distribution, and the measured PS distribution. The study shows that optimization of individual light source positions and intensities are feasible for the heterogeneous prostate during PDT.

Entities:  

Keywords:  Cimmino Optimization; PDT dose; Photodynamic therapy; light dosimetry; photosensitizer distribution; prostate

Year:  2009        PMID: 25914793      PMCID: PMC4407703          DOI: 10.1117/12.809897

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  15 in total

1.  Speed and convergence properties of gradient algorithms for optimization of IMRT.

Authors:  Xiaodong Zhang; Helen Liu; Xiaochun Wang; Lei Dong; Qiuwen Wu; Radhe Mohan
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

2.  Optimization of brachytherapy dose distributions by simulated annealing.

Authors:  R S Sloboda
Journal:  Med Phys       Date:  1992 Jul-Aug       Impact factor: 4.071

3.  Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.

Authors:  Jun Li; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2008-03-27       Impact factor: 3.609

4.  Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Jarod C Finlay; Timothy C Zhu; Andreea Dimofte; Diana Stripp; S Bruce Malkowicz; Theresa M Busch; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2006 Sep-Oct       Impact factor: 3.421

5.  Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Authors:  Kosmas Verigos; Diana C Hsiung Stripp; Rosemarie Mick; Timothy C Zhu; Richard Whittington; Debbie Smith; Andreea Dimofte; Jarod Finlay; Theresa M Busch; Zelig A Tochner; S Malkowicz; Eli Glatstein; Stephen M Hahn
Journal:  J Environ Pathol Toxicol Oncol       Date:  2006       Impact factor: 3.567

6.  Prostate PDT dosimetry.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Photodiagnosis Photodyn Ther       Date:  2006-10-19       Impact factor: 3.631

7.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Authors:  Timothy C Zhu; Andreea Dimofte; Jarod C Finlay; Diana Stripp; Theresa Busch; Jeremy Miles; Richard Whittington; S Bruce Malkowicz; Zelig Tochner; Eli Glatstein; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

8.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

9.  Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.

Authors:  Hiral Patel; Rosemarie Mick; Jarod Finlay; Timothy C Zhu; Elizabeth Rickter; Keith A Cengel; S Bruce Malkowicz; Stephen M Hahn; Theresa M Busch
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

10.  Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.

Authors:  Jun Li; Martin D Altschuler; Stephen M Hahn; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2008-07-08       Impact factor: 3.609

View more
  2 in total

1.  A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.

Authors:  Timothy C Zhu; Martin D Altschuler; Yida Hu; Ken Wang; Jarod C Finlay; Andreea Dimofte; Keith Cengel; Stephen M Hahn
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01

2.  Automatic interstitial photodynamic therapy planning via convex optimization.

Authors:  Abdul-Amir Yassine; William Kingsford; Yiwen Xu; Jeffrey Cassidy; Lothar Lilge; Vaughn Betz
Journal:  Biomed Opt Express       Date:  2018-01-30       Impact factor: 3.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.